Agenus, Inc. (AGEN)
6.33
-0.18
(-2.76%)
USD |
NASDAQ |
Oct 23, 16:00
6.32
-0.01
(-0.16%)
After-Hours: 20:00
Agenus Price : 6.33 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 6.36 | 6.50 | 6.16 | 6.33 | 510514.0 |
| Oct 22, 2026 | 6.32 | 6.53 | 6.236 | 6.51 | 553954.0 |
| Oct 21, 2026 | 6.43 | 6.54 | 6.31 | 6.40 | 789683.0 |
| Oct 20, 2026 | 6.10 | 6.58 | 6.05 | 6.42 | 827183.0 |
| Oct 19, 2026 | 6.13 | 6.30 | 6.055 | 6.18 | 734956.0 |
| Oct 16, 2026 | 6.65 | 6.70 | 6.00 | 6.04 | 1.029M |
| Oct 15, 2026 | 6.52 | 6.99 | 6.51 | 6.68 | 815431.0 |
| Oct 14, 2026 | 6.88 | 7.14 | 6.46 | 6.50 | 980140.0 |
| Oct 13, 2026 | 7.30 | 7.34 | 6.805 | 6.95 | 995561.0 |
| Oct 12, 2026 | 7.625 | 7.66 | 7.39 | 7.43 | 572490.0 |
| Oct 09, 2026 | 7.495 | 7.793 | 7.38 | 7.67 | 710289.0 |
| Oct 08, 2026 | 7.565 | 7.66 | 7.24 | 7.54 | 1.215M |
| Oct 07, 2026 | 7.28 | 7.62 | 7.27 | 7.57 | 1.156M |
| Oct 06, 2026 | 8.49 | 8.49 | 7.47 | 7.49 | 1.527M |
| Oct 05, 2026 | 8.54 | 8.76 | 8.110 | 8.73 | 956304.0 |
| Oct 02, 2026 | 8.36 | 8.613 | 8.08 | 8.36 | 1.086M |
| Oct 01, 2026 | 9.95 | 9.99 | 8.28 | 8.33 | 1.952M |
| Sep 30, 2026 | 9.92 | 10.31 | 9.62 | 9.93 | 1.367M |
| Sep 29, 2026 | 9.66 | 10.06 | 9.43 | 9.89 | 1.501M |
| Sep 28, 2026 | 8.71 | 9.71 | 8.47 | 9.43 | 2.766M |
| Sep 25, 2026 | 8.57 | 8.68 | 8.40 | 8.54 | 672403.0 |
| Sep 24, 2026 | 8.32 | 8.60 | 8.20 | 8.50 | 636610.0 |
| Sep 23, 2026 | 8.70 | 8.70 | 8.39 | 8.40 | 610168.0 |
| Sep 22, 2026 | 8.26 | 8.82 | 8.16 | 8.70 | 994137.0 |
| Sep 21, 2026 | 7.80 | 8.60 | 7.60 | 8.33 | 1.300M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Halozyme Therapeutics, Inc. | 125.63 |
| AVITA Medical, Inc. | 15.51 |
| Iovance Biotherapeutics, Inc. | 14.09 |
| Amgen, Inc. | 439.26 |
| Anika Therapeutics, Inc. | 21.42 |
Price Related Metrics
| PE Ratio | 2.388 |
| PS Ratio | 1.763 |
| Earnings Yield | 41.88% |
| Market Cap | 269.76M |
| Operating PE Ratio | 6.518 |
| Normalized PE Ratio | 6.341 |